SHANNON CHIN: Open Payments
NPI 1003366287 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,791 in 119 payments from 21 companies in 2025. Trend: 2023 $3,076 · 2024 $3,728 · 2025 $2,791
Food & beverage: $2,706Education: $85
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $491 |
| Janssen Biotech, Inc. | 11 | $418 |
| Phathom Pharmaceuticals, Inc. | 3 | $386 |
| ABBVIE INC. | 24 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $226 |
| Ardelyx, Inc. | 16 | $211 |
| Lilly USA, LLC | 10 | $145 |
| Aimmune Therapeutics, Inc. | 4 | $87 |
| Novo Nordisk Inc | 3 | $77 |
| Amgen Inc. | 3 | $71 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, IBSRELA, RINVOQ, ENTYVIO, OMVOH, UPLIZNA.
Industry payments across FL — which companies pay providers there.
